- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
North China Pharmaceutical Co Ltd (600812)
North China Pharmaceutical Co Ltd stock price live, this page displays SS 600812 stock exchange data. View the 600812 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the North China Pharmaceutical Co Ltd real time stock price chart below.
What Is the North China Pharmaceutical Co Ltd Stock Price Today?
The North China Pharmaceutical Co Ltd stock price today is 6.63.
What Is the Stock Symbol for North China Pharmaceutical Co Ltd?
The stock symbol for North China Pharmaceutical Co Ltd is ""600812.""
What Stock Exchange Does North China Pharmaceutical Co Ltd Trade On?
North China Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is North China Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether North China Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600812 quote. (ISIN: CNE000000D16)
What Is the North China Pharmaceutical Co Ltd Stock Price Today?
The North China Pharmaceutical Co Ltd stock price today is 6.63.
What Is the Stock Symbol for North China Pharmaceutical Co Ltd?
The stock symbol for North China Pharmaceutical Co Ltd is ""600812.""
What Stock Exchange Does North China Pharmaceutical Co Ltd Trade On?
North China Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is North China Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether North China Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600812 quote. (ISIN: CNE000000D16)
Shanghai
Currency in CNY
6.63
+0.04(+0.61%)
Closed·
Fair Value
An estimate of a North China Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.55
6.65
52 wk Range
4.41
7.46
600812 Scorecard
Full Analysis
Trading at a high earnings multiple
600812 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a North China Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.556.65
52 wk Range
4.417.46
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600812 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a North China Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
7.30
Upside
+10.11%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
North China Pharmaceutical Co Ltd Company Profile
North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China. The company primarily offers anti-infective drugs; biotechnology drugs; cardiovascular cerebrovascular; immunomodulators; and vitamins and health products. It also provides chemical pharmaceuticals, biological agricultural and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is based in Shijiazhuang, China.
Compare 600812 to Peers and Sector
Metrics to compare | 600812 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600812PeersSector | |
|---|---|---|---|---|
P/E Ratio | 68.4x | 25.4x | −0.5x | |
PEG Ratio | 0.09 | 0.12 | 0.00 | |
Price/Book | 2.1x | 2.4x | 2.6x | |
Price / LTM Sales | 1.2x | 2.9x | 3.3x | |
Upside (Analyst Target) | 10.1% | 12.5% | 43.4% | |
Fair Value Upside | Unlock | 20.7% | 7.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.30
(+10.11% Upside)
Earnings
Latest Release
Apr 23, 2025
EPS / Forecast
0.03 / --
Revenue / Forecast
2.57B / --
FAQ
What Stock Exchange Does North China Pharm Trade On?
North China Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.
What Is the Stock Symbol for North China Pharm?
The stock symbol for North China Pharm is "600812."
What Is the North China Pharm Market Cap?
As of today, North China Pharm market cap is 11.38B.
What Is North China Pharm's Earnings Per Share (TTM)?
The North China Pharm EPS (TTM) is 0.10.
From a Technical Analysis Perspective, Is 600812 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has North China Pharm Stock Split?
North China Pharm has split 2 times.
How Many Employees Does North China Pharm Have?
North China Pharm has 10088 employees.
What is the current trading status of North China Pharm (600812)?
As of 10 Aug 2025, North China Pharm (600812) is trading at a price of 6.63, with a previous close of 6.59. The stock has fluctuated within a day range of 6.55 to 6.65, while its 52-week range spans from 4.41 to 7.46.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.